International Stem Cell Corp. (ISCO.OB) Teams with The Automation Partnership to Accelerate and Ramp-up Synthetic Corneal Tissue
International Stem Cell Corp. today announced its strategic alliance with The Automation Partnership (TAP) to automate and increase the production of stem cell-derived human corneal tissue to produce commercial volumes of the tissue for cornea transplants and to reduce the use of animals in product testing. TAP provides advanced automation systems and services to improve productivity in life science research, development and production. TAP CEO David Newble said the partnership enforces its efforts to provide equipment for life science applications, and gives it an entrance to the biomedical market. "TAP has successfully installed and supported over 160 automated cell culture…